Advisory Committee on Immunization Practices (ACIP); Amended Notice of Meeting, 61766-61767 [2021-24320]

Download as PDF 61766 Federal Register / Vol. 86, No. 213 / Monday, November 8, 2021 / Notices I. Purpose In accordance with section 10(a) of the Federal Advisory Committee Act, 5 U.S.C. App., this notice announces a meeting of the National Advisory Council for Healthcare Research and Quality (the Council). The Council is authorized by Section 941 of the Public Health Service Act, 42 U.S.C. 299c. In accordance with its statutory mandate, the Council is to advise the Secretary of the Department of Health and Human Services and the Director of AHRQ on matters related to AHRQ’s conduct of its mission including providing guidance on (A) priorities for health care research, (B) the field of health care research including training needs and information dissemination on health care quality and (C) the role of the Agency in light of private sector activity and opportunities for public private partnerships. The Council is composed of members of the public, appointed by the Secretary, and Federal ex-officio members specified in the authorizing legislation. II. Agenda On Wednesday, November 17, 2021, the Council meeting will convene at 10:00 a.m., with the call to order by the Council Chair and approval of previous Council summary notes. The meeting will begin with an introduction of new NAC members and then an update on AHRQ’s Subcommittee of the National Advisory Council (SNAC) on Healthcare Quality Measurement. The agenda will also include a discussion on primary care. The meeting will adjourn at 3:00 p.m. The meeting is open to the public. For information regarding how to access the meeting as well as other meeting details, including information on how to make a public comment, please go to https:// www.ahrq.gov/news/events/nac/. The final agenda will be available on the AHRQ website no later than Thursday, November 11, 2021. Dated: November 2, 2021. Marquita Cullom, Associate Director. [FR Doc. 2021–24296 Filed 11–5–21; 8:45 am] BILLING CODE 4160–90–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Advisory Council for the Elimination of Tuberculosis (ACET) Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice of meeting. AGENCY: In accordance with the Federal Advisory Committee Act, the CDC announces the following meeting of the Advisory Council for the Elimination of Tuberculosis Meeting (ACET). This meeting is open to the public and limited to 1,000 audio and web conference lines. Time will be available for public comment. DATES: The meeting will be held on December 14, 2021, from 10:00 a.m. to 3:45 p.m., EST, and December 15, 2021, from 10:00 a.m. to 12:00 p.m., EST. The public is welcome to submit written comments in advance of the meeting. Comments should be submitted in writing by email to the contact person listed below. In the subject line, please note ATTN: Staci Morris for ACET Public Comment. The public comment should include your name, affiliation, and email address. Comments must be received on or before December 13, 2021. ADDRESSES: The web conference access is: https://cdc.zoomgov.com/j/ 1612312595?pwd=WnhzbDdEZGJIQXc 1UkhoN2sxU05IUT09. Passcode: H&0uhKFm. Webinar ID: 161 231 2595. The teleconference access is noted as follows: Telephone number: 1–669–254–5252; and the passcode is 49252654. FOR FURTHER INFORMATION CONTACT: Staci Morris, Committee Management Specialist, National Center for HIV, Viral Hepatitis, STD, and TB Prevention (NCHHSTP), CDC, 1600 Clifton Road NE, Mailstop US8–6, Atlanta, Georgia 30329–4027; Telephone: (404) 718– 7479; Email: nchhstppolicy@cdc.gov. (In the subject line, please note ATTN: Staci Morris for ACET Public Comment). SUMMARY: lotter on DSK11XQN23PROD with NOTICES1 SUPPLEMENTARY INFORMATION: Purpose: The Council advises and makes recommendations to the Secretary of Health and Human Services, the Assistant Secretary for Health, and the Director, CDC, regarding the elimination of tuberculosis (TB). Specifically, the Council makes VerDate Sep<11>2014 18:37 Nov 05, 2021 Jkt 256001 PO 00000 Frm 00020 Fmt 4703 Sfmt 4703 recommendations regarding policies, strategies, objectives, and priorities; addresses the development and application of new technologies; and reviews the extent to which progress has been made toward eliminating tuberculosis. Matters To Be Considered: The agenda will include discussions on: (1) Study 31 Regimen Guidance; (2) TB Epidemiologic Studies Consortium; (3) Latent Tuberculosis Infection (LTBI) Campaign; (4) NCHHSTP and Division of Tuberculosis Elimination Equity Activities; (5) Electronic Directly Observed Therapy (eDOT) Study; and (6) Multi-State TB Outbreak Associated with Bone Allograft Surgery. Agenda items are subject to change as priorities dictate. The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Kalwant Smagh, Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2021–24321 Filed 11–5–21; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [Docket No. CDC–2021–0098] Advisory Committee on Immunization Practices (ACIP); Amended Notice of Meeting Centers for Disease Control and Prevention, Department of Health and Human Services (HHS). ACTION: Notice. AGENCY: In accordance with the Federal Advisory Committee Act, the Centers for Disease Control and Prevention (CDC), announces the following meeting of the Advisory Committee on Immunization Practices (ACIP). This meeting is open to the public. Time will be available for public comment. The meeting will be webcast live via the World Wide Web; for more information on ACIP please visit the ACIP website: https://www.cdc.gov/ vaccines/acip/. SUMMARY: E:\FR\FM\08NON1.SGM 08NON1 Federal Register / Vol. 86, No. 213 / Monday, November 8, 2021 / Notices The meeting will be held on October 20–21, 2021, from 10:00 a.m. to 5:00 p.m., EDT (times subject to change). The docket is currently open to receive written comments. Written comments must be received on or before October 21, 2021. SUPPLEMENTARY INFORMATION: Notice is hereby given of a change in the meeting of the Advisory Committee on Immunization Practices (ACIP); October 20, 2021, 10:00 a.m.–5:00 p.m., EDT, and October 21, 2021, 10:00 a.m.–5:00 p.m., EDT (times subject to change), in the original FRN. The virtual meeting was published in the Federal Register on Wednesday, September 22, 2021, Volume 86, Number 181, pages 52683–52684. The virtual meeting is being amended to change the date the docket was opened to receive written public comments, and updates to the Matters To Be Considered and Written Public Comment sections of the notice and should read as follows: DATES: The meeting will be held on October 20–21, 2021, from 10:00 a.m. to 5:00 p.m., EDT (times subject to change). The public may submit written comments from October 7, 2021 through October 21, 2021. Matters To Be Considered: The agenda will include discussions on herpes zoster vaccines, influenza vaccines, pneumococcal vaccine, and COVID–19 vaccines. Recommendation votes on herpes zoster vaccine, pneumococcal vaccine, and COVID–19 vaccines are scheduled. No Vaccines for Children (VFC) votes are scheduled. Agenda items are subject to change as priorities dictate. For more information on ACIP please visit the ACIP website: https:// www.cdc.gov/vaccines/acip/. Written Public Comment: The docket will be opened to receive written comments on October 7, 2021. Written comments must be received on or before October 21, 2021. The virtual meeting is open to the public. FOR FURTHER INFORMATION CONTACT: Stephanie Thomas, ACIP Committee Management Specialist, Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, 1600 Clifton Road NE, MS–H24–8, Atlanta, GA 30329– 4027; Telephone: 404–639–8367; Email: ACIP@cdc.gov. The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other lotter on DSK11XQN23PROD with NOTICES1 DATES: VerDate Sep<11>2014 18:37 Nov 05, 2021 Jkt 256001 committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Kalwant Smagh, Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. 61767 Prevention and the Agency for Toxic Substances and Disease Registry. Kalwant Smagh, Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2021–24322 Filed 11–5–21; 8:45 am] BILLING CODE 4163–18–P [FR Doc. 2021–24320 Filed 11–5–21; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended, and the Determination of the Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, CDC, pursuant to Public Law 92–463. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)—RFA–CK–22–003, Emerging Infections Sentinel Networks (EISN) Research. Date: January 11, 2022. Time: 10:00 a.m.–5:00 p.m., EST. Place: Teleconference, Centers for Disease Control and Prevention, Room 1080, 8 Corporate Square Boulevard, Atlanta, Georgia 30329–4027. Agenda: To review and evaluate grant applications. For Further Information Contact: Gregory Anderson, M.S., M.P.H., Scientific Review Officer, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, CDC, 1600 Clifton Road NE, Mailstop US8–1, Atlanta, Georgia 30329–4027, Telephone: (404) 718–8833, Email: GAnderson@cdc.gov. The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and PO 00000 Frm 00021 Fmt 4703 Sfmt 4703 Centers for Medicare & Medicaid Services [Document Identifiers: CMS–10280] Agency Information Collection Activities: Submission for OMB Review; Comment Request Centers for Medicare & Medicaid Services, Health and Human Services (HHS). ACTION: Notice. AGENCY: The Centers for Medicare & Medicaid Services (CMS) is announcing an opportunity for the public to comment on CMS’ intention to collect information from the public. Under the Paperwork Reduction Act of 1995 (PRA), federal agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension or reinstatement of an existing collection of information, and to allow a second opportunity for public comment on the notice. Interested persons are invited to send comments regarding the burden estimate or any other aspect of this collection of information, including the necessity and utility of the proposed information collection for the proper performance of the agency’s functions, the accuracy of the estimated burden, ways to enhance the quality, utility, and clarity of the information to be collected, and the use of automated collection techniques or other forms of information technology to minimize the information collection burden. SUMMARY: Comments on the collection(s) of information must be received by the OMB desk officer by December 8, 2021. ADDRESSES: Written comments and recommendations for the proposed information collection should be sent within 30 days of publication of this notice to www.reginfo.gov/public/do/ PRAMain. Find this particular information collection by selecting ‘‘Currently under 30-day Review—Open for Public Comments’’ or by using the search function. DATES: E:\FR\FM\08NON1.SGM 08NON1

Agencies

[Federal Register Volume 86, Number 213 (Monday, November 8, 2021)]
[Notices]
[Pages 61766-61767]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-24320]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[Docket No. CDC-2021-0098]


Advisory Committee on Immunization Practices (ACIP); Amended 
Notice of Meeting

AGENCY: Centers for Disease Control and Prevention, Department of 
Health and Human Services (HHS).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, the 
Centers for Disease Control and Prevention (CDC), announces the 
following meeting of the Advisory Committee on Immunization Practices 
(ACIP). This meeting is open to the public. Time will be available for 
public comment. The meeting will be webcast live via the World Wide 
Web; for more information on ACIP please visit the ACIP website: https://www.cdc.gov/vaccines/acip/.

[[Page 61767]]


DATES: The meeting will be held on October 20-21, 2021, from 10:00 a.m. 
to 5:00 p.m., EDT (times subject to change). The docket is currently 
open to receive written comments. Written comments must be received on 
or before October 21, 2021.

SUPPLEMENTARY INFORMATION: Notice is hereby given of a change in the 
meeting of the Advisory Committee on Immunization Practices (ACIP); 
October 20, 2021, 10:00 a.m.-5:00 p.m., EDT, and October 21, 2021, 
10:00 a.m.-5:00 p.m., EDT (times subject to change), in the original 
FRN.
    The virtual meeting was published in the Federal Register on 
Wednesday, September 22, 2021, Volume 86, Number 181, pages 52683-
52684.
    The virtual meeting is being amended to change the date the docket 
was opened to receive written public comments, and updates to the 
Matters To Be Considered and Written Public Comment sections of the 
notice and should read as follows:

DATES: The meeting will be held on October 20-21, 2021, from 10:00 a.m. 
to 5:00 p.m., EDT (times subject to change). The public may submit 
written comments from October 7, 2021 through October 21, 2021.

    Matters To Be Considered: The agenda will include discussions on 
herpes zoster vaccines, influenza vaccines, pneumococcal vaccine, and 
COVID-19 vaccines. Recommendation votes on herpes zoster vaccine, 
pneumococcal vaccine, and COVID-19 vaccines are scheduled. No Vaccines 
for Children (VFC) votes are scheduled. Agenda items are subject to 
change as priorities dictate. For more information on ACIP please visit 
the ACIP website: https://www.cdc.gov/vaccines/acip/.
    Written Public Comment: The docket will be opened to receive 
written comments on October 7, 2021. Written comments must be received 
on or before October 21, 2021.
    The virtual meeting is open to the public.

FOR FURTHER INFORMATION CONTACT: Stephanie Thomas, ACIP Committee 
Management Specialist, Centers for Disease Control and Prevention, 
National Center for Immunization and Respiratory Diseases, 1600 Clifton 
Road NE, MS-H24-8, Atlanta, GA 30329-4027; Telephone: 404-639-8367; 
Email: [email protected].
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2021-24320 Filed 11-5-21; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.